Structure via PubChem · Public domain (PubChem)
CX546
Sign in to saveAlso known as CX 546, CX-546
CX-546 is an ampakine drug developed by Cortex Pharmaceuticals.
Chemical data
- Formula
- C14H17NO3
- Molecular weight
- 247.29 g/mol
- IUPAC name
- 2,3-dihydro-1,4-benzodioxin-6-yl(piperidin-1-yl)methanone
- SMILES
- C1CCN(CC1)C(=O)C2=CC3=C(C=C2)OCCO3
- InChIKey
- LJUNPHMOGNFFOS-UHFFFAOYSA-N
- XLogP
- 1.1
- Polar surface area
- 38.8 Ų
- H-bond donors
- 0
- H-bond acceptors
- 3
- Formal charge
- 0
via PubChem
Drug data · ChEMBL
- Molecule type
- Small molecule
via ChEMBL · EBI
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 247.120843
Show 2 more facts
- chemical formula
- C₁₄H₁₇NO₃
- canonical SMILES
- C1CCN(CC1)C(=O)C2=CC3=C(C=C2)OCCO3
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
CX-546 is an ampakine drug developed by Cortex Pharmaceuticals.
It has been proposed as a treatment for schizophrenia. CX-546 was the second drug of note to come out of the Cortex research program, after CX-516, but while it was an improvement over its predecessor in some respects, it still has problems with limited oral bioavailability.
Excerpted from Wikipedia’s “CX546” article, available under the CC BY-SA 4.0 licence.